- Baraibar, I., Morabito, S., Nieto, J., Deuner, G., Melero, J. L., Salva, F., Grzelak, M., Ros Montañá, J., Caratu, G., Perez-Lopez, R., Nieto, P., Rotem, A., Casbas-Hernandez, P., Martinez-Martin, N., Gros, A., Tabernero, J., & Elez, E. (2026). The SERPENTINE trial: A phase II clinical study decoding immune responses by scRNA-seq and TCR-seq analysis in patients with MSS metastatic colorectal cancer (Mcrc) with and without liver metastases treated with durvalumab and tremelimumab. Journal of Clinical Oncology, 44(16_suppl), 3607-3607. https://doi.org/10.1200/JCO.2026.44.16_suppl.3607 (Meeting abstract)
The SERPENTINE trial: A phase II clinical study decoding immune responses by scRNA-seq and TCR-seq analysis in patients with MSS metastatic colorectal cancer (Mcrc) with and without liver metastases treated with durvalumab and tremelimumab
on 19 d'octubre de 2026
with No hi ha comentaris
Deixa un comentari